Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

Abstract

Risk scores in patients with atrial fibrillation (AF) based on clinical factors alone generally have only modest predictive value for predicting high risk patients that sustain events. Biomarkers might be an attractive prognostic tool to improve bleeding risk prediction. The new ABC-Bleeding score performed better than HAS-BLED score in a clinical trial cohort but has not been externally validated. The aim of this study was to analyze the predictive performance of the ABC-Bleeding score compared to HAS-BLED score in an independent "real-world" anticoagulated AF patients with long-term follow-up. We enrolled 1,120 patients stable on vitamin K antagonist treatment. The HAS-BLED and ABC-Bleeding scores were quantified. Predictive values were compared by c-indexes, IDI, NRI, as well as decision curve analysis (DCA). Median HAS-BLED score was 2 (IQR 2-3) and median ABC-Bleeding was 16.5 (IQR 14.3-18.6). After 6.5 years of follow-up, 207 (2.84 %/year) patients had major bleeding events, of which 65 (0.89 %/year) had intracranial haemorrhage (ICH) and 85 (1.17 %/year) had gastrointestinal bleeding events (GIB). The c-index of HAS-BLED was significantly higher than ABC-Bleeding for major bleeding (0.583 vs 0.518; p=0.025), GIB (0.596 vs 0.519; p=0.017) and for the composite of ICH-GIB (0.593 vs 0.527; p=0.030). NRI showed a significant negative reclassification for major bleeding and for the composite of ICH-GIB with the ABC-Bleeding score compared to HAS-BLED. Using DCAs, the use of HAS-BLED score gave an approximate net benefit of 4 % over the ABC-Bleeding score. In conclusion, in the first "real-world" validation of the ABC-Bleeding score, HAS-BLED performed significantly better than the ABC-Bleeding score in predicting major bleeding, GIB and the composite of GIB and ICH.

A nomogram for determining the disease-specific survival in Ewing sarcoma: a population study

“…Finally, our newly constructed nomogram model included a wide range of clinical risk factors, namely, age at diagnosis, race, EOD, tumor size, and surgery, which were easily available and routinely collected from historical records. Figure 4 shows the results of our DCA, wherein the abscissa and ordinate are the threshold probability and net benefit rate, respectively [28–31]. To the best of our knowledge, this study is the first to use IDI, NRI, and DCA in the verification of the predictive abilities of nomograms for ES.…”

A nomogram for determining the disease-specific survival in invasive lobular carcinoma of the breast

“…Figure 4 shows the results of DCAs, with the abscissa corresponding to the threshold probability and the ordinate being the net benefit rate. [ 34 – 36 ] The figure illustrates that the new model yielded net benefits that were superior to those of the traditional AJCC staging system. These results together demonstrate that our nomogram would provide useful information about the risks and benefits of certain treatment plans, thereby helping clinicians to make good decisions and even provide psychological support.…”

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

“…Real-world studies investigating the usefulness of sequential addition of biomarkers have shown limited value over conventional clinical risk scores. 10 , 308 , 309 Thus, statistically significant improved prediction should not be confused with clinically improved risk prediction. A balance is therefore needed between (statistically) improved risk prediction and simplicity or practicality for everyday clinical use in busy clinical settings.…”